Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients
Authors
Keywords
Acute myeloid leukemia, Induction chemotherapy, Next-generation sequencing, Older patients
Journal
Cancer Cell International
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-22
DOI
10.1186/s12935-018-0716-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
- (2018) Ann-Kathrin Eisfeld et al. LEUKEMIA
- Chinese and Europeans with acute myeloid leukemia have discordant mutation topographies
- (2018) Min Zhang et al. LEUKEMIA RESEARCH
- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
- (2016) K. H. Metzeler et al. BLOOD
- Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
- (2016) C-H Tsai et al. LEUKEMIA
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
- (2015) D. Grimwade et al. BLOOD
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1 and TET2 mutations
- (2014) Robert S Ohgami et al. MODERN PATHOLOGY
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia
- (2011) Y. Shen et al. BLOOD
- ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
- (2011) K. H. Metzeler et al. BLOOD
- Therapeutic Advances in Acute Myeloid Leukemia
- (2011) Alan Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
- (2010) I. H. I. M. Hollink et al. HAEMATOLOGICA
- Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis
- (2009) T Pabst et al. BRITISH JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now